Ultrastructural Study of the Effects of Hybrid Compounds of Natural Monoterpene Carvacrol and Synthetic Cationic Amphiphile DL412 on S. aureus and E. faecalis Cells
Abstract
1. Introduction
2. Results
2.1. Ultrastructure of S. aureus and E. faecalis Intact Cells
2.2. S. aureus and E. faecalis Ultrastructure Alteration by DL412
2.3. S. aureus Ultrastructure Alteration by DL4CAR-6, DL5CAR-6, DLpCAR-6 and DLoCAR-6 Compounds
2.4. E. faecalis Ultrastructure Alteration by DL4CAR-6
2.5. E. faecalis Ultrastructure Alteration by DL5CAR-6
2.6. E. faecalis Ultrastructure Alteration by DLpCAR-6
2.7. E. faecalis Ultrastructure Alteration by DLoCAR-6
3. Discussion
- (1)
- DL4CAR-6: the central linker was identical to DL412 (tetramethylene);
- (2)
- DL5CAR-6: the central linker was longer (pentamethylene);
- (3)
- DLoCAR-6: a benzene group formed the central linker (aromatic linker replaced the aliphatic one);
- (4)
- DLpCAR-6: the central linker was formed by a p-xylene molecule (aromatic).
4. Materials and Methods
4.1. Antibacterial Compounds
4.2. Microorganisms and Their Incubation with ABCs
4.3. Determination of Minimum Inhibitory Concentrations (MICs)
4.4. Samples Processing for TEM Study
4.5. Ultrastructure Analysis of Damaged Cells
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Qiao, W.; Wang, L.; Luo, Y.; Yang, T. Synthetic approaches and therapeutic applications of FDA-approved antibacterial agents: A comprehensive review from 2003 to 2023. Eur. J. Med. Chem. 2025, 285, 117267. [Google Scholar] [CrossRef]
- Kaur, N.; Sahoo, J.; De, M. Development of Nanomaterials-Based Agents for Selective Antibacterial Activity. Chembiochem 2025, 26, e202400693. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. Antibacterial Agents in Clinical and Preclinical Development: An Overview and Analysis, 1st ed.; World Health Organization: Geneva, Switzerland, 2024. [Google Scholar]
- Heimann, D.; Kohnhauser, D.; Kohnhauser, A.J.; Bronstrup, M. Antibacterials with Novel Chemical Scaffolds in Clinical Development. Drugs 2025, 85, 293–323. [Google Scholar] [CrossRef] [PubMed]
- Oliveira Junior, N.G.; Souza, C.M.; Buccini, D.F.; Cardoso, M.H.; Franco, O.L. Antimicrobial peptides: Structure, functions and translational applications. Nat. Rev. Microbiol. 2025, 23, 687–700. [Google Scholar] [CrossRef]
- Del Olmo, M.L.; Andreu, C. Current Status of the Application of Antimicrobial Peptides and Their Conjugated Derivatives. Molecules 2025, 30, 3070. [Google Scholar] [CrossRef] [PubMed]
- Grigor’eva, A.; Bardasheva, A.; Tupitsyna, A.; Amirkhanov, N.; Tikunova, N.; Pyshnyi, D.; Ryabchikova, E. Changes in the Ultrastructure of Staphylococcus aureus Treated with Cationic Peptides and Chlorhexidine. Microorganisms 2020, 8, 1991. [Google Scholar] [CrossRef]
- Ghosh, C.; Haldar, J. Membrane-Active Small Molecules: Designs Inspired by Antimicrobial Peptides. ChemMedChem 2015, 10, 1606–1624. [Google Scholar] [CrossRef]
- Burakova, E.A.; Silnikov, V.N. Molecular design of artificial ribonucleases using electrostatic interaction. Nucleosides Nucleotides Nucleic Acids 2004, 23, 915–920. [Google Scholar] [CrossRef]
- Burakova, E.A.; Saranina, I.V.; Tikunova, N.V.; Sil’nikov, V.N. Tetracationic compounds based on 1,4-diazabicyclo[2.2.2]octane: Antibacterial activity and reactions with N-containing nucleophiles. Russ. Chem. Bull. 2015, 64, 1400–1405. [Google Scholar] [CrossRef]
- Burakova, E.A.; Saranina, I.V.; Tikunova, N.V.; Nazarkina, Z.K.; Laktionov, P.P.; Karpinskaya, L.A.; Anikin, V.B.; Zarubaev, V.V.; Silnikov, V.N. Biological evaluation of tetracationic compounds based on two 1,4-diazabicyclo[2.2.2]octane moieties connected by different linkers. Bioorg. Med. Chem. 2016, 24, 6012–6020. [Google Scholar] [CrossRef]
- Yarinich, L.A.; Burakova, E.A.; Zakharov, B.A.; Boldyreva, E.V.; Babkina, I.N.; Tikunova, N.V.; Silnikov, V.N. Synthesis and structure-activity relationship of novel 1,4-diazabicyclo[2.2.2]octane derivatives as potent antimicrobial agents. Eur. J. Med. Chem. 2015, 95, 563–573. [Google Scholar] [CrossRef] [PubMed]
- Grigor’eva, A.E.; Bardasheva, A.V.; Ryabova, E.S.; Tupitsyna, A.V.; Zadvornykh, D.A.; Koroleva, L.S.; Silnikov, V.N.; Tikunova, N.V.; Ryabchikova, E.I. Changes in the Ultrastructure of Staphylococcus aureus Cells Make It Possible to Identify and Analyze the Injuring Effects of Ciprofloxacin, Polycationic Amphiphile and Their Hybrid. Microorganisms 2023, 11, 2192. [Google Scholar] [CrossRef] [PubMed]
- Grigor’eva, A.E.; Tupitsyna, A.V.; Ryabova, E.S.; Bardasheva, A.V.; Zadvornykh, D.A.; Koroleva, L.S.; Silnikov, V.N.; Ryabchikova, E.I. Ribosome Disorganization and Other Effects of Artifitial RNAse DL412 on Salmonella enterica Cells. Appl. Biochem. Microbiol. 2025, 61, 228–237, Erratum in Appl. Biochem. Microbiol. 2025, 61, 1839. [Google Scholar] [CrossRef]
- Zadvornykh, D.; Zhang, Z.; Liu, C.; Serpokrylova, I.; Bardasheva, A.; Tikunova, N.; Silnikov, V.; Koroleva, L. Antibacterial activity of cationic amphiphil conjugates with ciprofloxacin. Int. J. Health Sci. 2022, 6, 3009–3023. [Google Scholar] [CrossRef]
- Ait-Ouazzou, A.; Espina, L.; Gelaw, T.K.; de Lamo-Castellvi, S.; Pagan, R.; Garcia-Gonzalo, D. New insights in mechanisms of bacterial inactivation by carvacrol. J. Appl. Microbiol. 2013, 114, 173–185. [Google Scholar] [CrossRef]
- Suntres, Z.E.; Coccimiglio, J.; Alipour, M. The bioactivity and toxicological actions of carvacrol. Crit. Rev. Food Sci. Nutr. 2015, 55, 304–318. [Google Scholar] [CrossRef]
- Latorre, R.; Valerii, M.C.; Benati, M.; Lewis, R.E.; Spigarelli, R.; Bernacchi, A.; Lippi, G.; Spisni, E.; Gaibani, P. Lights and Shadows of Essential Oil-Derived Compounds: Antimicrobial and Anti-Inflammatory Properties of Eugenol, Thymol, Cinnamaldehyde, and Carvacrol. Curr. Issues Mol. Biol. 2025, 47, 915. [Google Scholar] [CrossRef]
- Radocchia, G.; Giammarino, A.; Barberini, S.; Verdolini, L.; De Angelis, M.; Simonetti, G.; Pantanella, F.; Schippa, S.; Angiolella, L. Carvacrol and Thymol, a Synergistic Antimicrobial Activity Against Bacterial and Candida Species. Microbiologyopen 2025, 14, e70089. [Google Scholar] [CrossRef]
- Hyldgaard, M.; Mygind, T.; Meyer, R.L. Essential oils in food preservation: Mode of action, synergies, and interactions with food matrix components. Front. Microbiol. 2012, 3, 12. [Google Scholar] [CrossRef]
- Bouhdid, S.; Abrini, J.; Zhiri, A.; Espuny, M.J.; Manresa, A. Investigation of functional and morphological changes in Pseudomonas aeruginosa and Staphylococcus aureus cells induced by Origanum compactum essential oil. J. Appl. Microbiol. 2009, 106, 1558–1568. [Google Scholar] [CrossRef]
- Bouhdid, S.; Abrini, J.; Amensour, M.; Zhiri, A.; Espuny, M.J.; Manresa, A. Functional and ultrastructural changes in Pseudomonas aeruginosa and Staphylococcus aureus cells induced by Cinnamomum verum essential oil. J. Appl. Microbiol. 2010, 109, 1139–1149. [Google Scholar] [CrossRef] [PubMed]
- Boeder, A.M.; Spiller, F.; Carlstrom, M.; Izidio, G.S. Enterococcus faecalis: Implications for host health. World J. Microbiol. Biotechnol. 2024, 40, 190. [Google Scholar] [CrossRef] [PubMed]
- Wang, Y.; Xu, W.; Guo, S.; Xu, S.; Wang, J.; Zhang, S.; Kuang, Y.; Jin, P. Enterococci for human health: A friend or foe? Microb. Pathog. 2025, 201, 107381. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. WHO Bacterial Priority Pathogens List, 2024: Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance; World Health Organization: Geneva, Switzerland, 2024; p. 72. [Google Scholar]
- Feng, J.; Zheng, Y.; Ma, W.; Ihsan, A.; Hao, H.; Cheng, G.; Wang, X. Multitarget antibacterial drugs: An effective strategy to combat bacterial resistance. Pharmacol. Ther. 2023, 252, 108550. [Google Scholar] [CrossRef]
- Gray, D.A.; Wenzel, M. Multitarget Approaches Against Multiresistant Superbugs. ACS Infect. Dis. 2020, 6, 1346–1365. [Google Scholar] [CrossRef]
- Lungu, I.A.; Moldovan, O.L.; Biris, V.; Rusu, A. Fluoroquinolones Hybrid Molecules as Promising Antibacterial Agents in the Fight Against Antibacterial Resistance. Pharmaceutics 2022, 14, 1749. [Google Scholar] [CrossRef]
- Monteiro, J.M.; Covas, G.; Rausch, D.; Filipe, S.R.; Schneider, T.; Sahl, H.G.; Pinho, M.G. The pentaglycine bridges of Staphylococcus aureus peptidoglycan are essential for cell integrity. Sci. Rep. 2019, 9, 5010. [Google Scholar] [CrossRef]
- Schleifer, K.H.; Kandler, O. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol. Rev. 1972, 36, 407–477. [Google Scholar] [CrossRef]
- Kuzminov, A. Bacterial nucleoid is a riddle wrapped in a mystery inside an enigma. J. Bacteriol. 2024, 206, e0021123. [Google Scholar] [CrossRef]
- European Committee for Antimicrobial Susceptibility Testing of the European Society of Clinical Microbiology and Infectious Diseases. Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin. Microbiol. Infect. 2003, 9, ix–xv. [Google Scholar] [CrossRef]





| Compounds | MIC (µM) | |
|---|---|---|
| E. faecalis | S. aureus | |
| DL412 | 63 | 4 |
| DL4CAR-6 | 63 | 4 |
| DL5CAR-6 | 250 | 8 |
| DLoCAR-6 | 250 | 8 |
| DLpCAR-6 | 500 | 8 |
| Ciprofloxacin * | 400 | 2 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Ryabova, E.S.; Grigor’eva, A.E.; Bardasheva, A.V.; Tupitsyna, A.V.; Zadvornykh, D.A.; Koroleva, L.S.; Ryabchikova, E.I. Ultrastructural Study of the Effects of Hybrid Compounds of Natural Monoterpene Carvacrol and Synthetic Cationic Amphiphile DL412 on S. aureus and E. faecalis Cells. Int. J. Mol. Sci. 2026, 27, 2217. https://doi.org/10.3390/ijms27052217
Ryabova ES, Grigor’eva AE, Bardasheva AV, Tupitsyna AV, Zadvornykh DA, Koroleva LS, Ryabchikova EI. Ultrastructural Study of the Effects of Hybrid Compounds of Natural Monoterpene Carvacrol and Synthetic Cationic Amphiphile DL412 on S. aureus and E. faecalis Cells. International Journal of Molecular Sciences. 2026; 27(5):2217. https://doi.org/10.3390/ijms27052217
Chicago/Turabian StyleRyabova, Elena S., Alina E. Grigor’eva, Alevtina V. Bardasheva, Anastasiya V. Tupitsyna, Danila A. Zadvornykh, Lyudmila S. Koroleva, and Elena I. Ryabchikova. 2026. "Ultrastructural Study of the Effects of Hybrid Compounds of Natural Monoterpene Carvacrol and Synthetic Cationic Amphiphile DL412 on S. aureus and E. faecalis Cells" International Journal of Molecular Sciences 27, no. 5: 2217. https://doi.org/10.3390/ijms27052217
APA StyleRyabova, E. S., Grigor’eva, A. E., Bardasheva, A. V., Tupitsyna, A. V., Zadvornykh, D. A., Koroleva, L. S., & Ryabchikova, E. I. (2026). Ultrastructural Study of the Effects of Hybrid Compounds of Natural Monoterpene Carvacrol and Synthetic Cationic Amphiphile DL412 on S. aureus and E. faecalis Cells. International Journal of Molecular Sciences, 27(5), 2217. https://doi.org/10.3390/ijms27052217

